| Home : November 2012 : November 28, 2012 News : Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012 |
Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012 |
November 28, 2012
GREENWOOD VILLAGE, Colo., Nov. 28, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (AMPE), a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual...
http://www.prnewswire.com/news-releases/ampio-pharmaceuticals-inc-ampe-announces-appointment-of-josh-disbrow-as-chief-operating-officer-effective-december-15-2012-181136701.html
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|